MediciNova, Inc. (MNOV)
$1.54+1.32%Close
SELLCRISIS · day 13
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $76M
- Beta
- 0.61
- P/E (TTM)
- -7.60
- Short % float
- 0.80%
- Days to cover
- 1.0
- SI change
- -9.5%
- 1W
- -12.50%
- 1M
- -14.92%
- vs SPY 1W
- -12.92%
- vs SPY 1M
- -16.98%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on MNOV?
- LOPJLB’s latest quantitative signal on MediciNova, Inc. (MNOV) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is MNOV in?
- MediciNova, Inc. (MNOV) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does MediciNova, Inc. (MNOV) do?
- MediciNova, Inc. is a biopharmaceutical firm dedicated to discovering and advancing innovative small molecule therapies for severe illnesses where current treatments are insufficient within the United States. Its robust development pipeline features MN-166 (ibudilast), an oral agent with both anti-inflammatory and neuroprotective properties, currently being investigated for a range of neurologi…